Open AccessAbility of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy
Author(s) -
N. S. FERDER,
C. S. EBY,
E. DEYCH,
J. K. HARRIS,
P. M. RIDKER,
P. E. MILLIGAN,
S. Z. GOLDHABER,
C. R. KING,
Tusar Giri,
H. L. MCLEOD,
R. J. GLYNN,
B. F. GAGE
Publication year - 2010
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jkcr-c710
Subject(s) - warfarin , cyp2c9 , vkorc1 , therapeutic index , medicine , therapeutic window , pharmacology , oncology , atrial fibrillation , drug , cytochrome p450 , metabolism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom